When the skin explant model was used for intradermal delivery of the melanoma-associated gp100280–288 peptide and MPLA-containing liposomes, these liposomes were efficiently taken up by CD14+ dermal DCs and MPLA inclusion resulted in a significant increase in CD8+ T cell response [196]. The gene discussed is CD8A; the disease is melanoma.